Copy Link Print Information

Tagitanlimab

(Synonyms: HBM-9167; KL-A167)
Revisión del cliente

Based on 1 Customer Validation

Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: ≥99.0%
  • No. CAS: 2417649-97-7
  • Peso molecular:144.95 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tagitanlimab
  • Experimental Validation Results for Tagitanlimab
  • Experimental Validation Results for Tagitanlimab
  • Tagitanlimab Chemical Structure
    Tagitanlimab Chemical Structure
No. CAS: 2417649-97-7
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tagitanlimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Human PD-L1/B7-H1 Protein (ECD) can bind Tagitanlimab. The EC50 for this effect is 8.34 ng/mL.

  • 1/16

    Flow cytometric analysis of 1.5X106 MDA-MB-231 cells labeling Tagitanlimab (HY-P99544, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Tagitanlimab Chemical Structure
    1/16
  • Tagitanlimab
  • Immobilized Human PD-L1/B7-H1 Protein (ECD) can bind Tagitanlimab. The EC50 for this effect is 8.34 ng/mL.
  • Flow cytometric analysis of 1.5X106 MDA-MB-231 cells labeling Tagitanlimab (HY-P99544, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).